Initiating the improved TRL Token Economics: new study onboarded
We’re excited to initiate our new TRL token economics with the newly onboarded multi-center cardiology clinical trial. This new study is also subject to the TRL Burn Accelerator program, which we launched in December last year. The details and transactions related to our token economics are outlined in this article.
Please note we use the words ‘clinical trial’ and ‘study’ interchangeable.
About the study
The newly onboarded clinical trial concerns a 28-month, multi-center, Pulmonary Arterial Hypertension study that includes 10 research sites and 500+ patients across the United States (details are provided in this press release).
The TRL Platform Fee
Triall charges a standardised fee called the TRL Platform Fee for each new clinical trial on the Triall platform. For this particular study, we adhere to the Ruby pricing tier of 5,000 USD due to the novelty of the client and the potential for future studies as part of the collaborative agreement. Triall’s primary objective is to onboard a growing number of studies over time. Each of these studies are subject to the TRL Platform Fee.
👉 Read this article if you’d like to get up to speed on the TRL token economics and its key advantages to TRL token holders.
The TRL Burn Accelerator
This new study is also subject to the TRL Burn Accelerator, a token reserve of 200,000 TRL tokens to be burned across the next 25 clinical trials onboarded into the Triall ecosystem (more info here). An additional 12,200 TRL has been burned for this study (see table below) as it is the second clinical trial to be onboarded since the launch of this program.
Token transactions
Below is an overview of how the TRL Platform Fee is used, including liquidity adds, TRL purchases, and token burns.
A total of 137,553.819 TRL has been purchased from the market over a 30-day period after which 41,378 TRL has been burned, which includes 29,178 for the study and 12,200 TRL as part of the $TRL Burn Accelerator program.
All purchase and burn transactions are portrayed in the table below. You can track all transactions via the block-explorer.
About Triall
Triall brings Web 3.0 to medical research by creating a digital ecosystem of blockchain-integrated software solutions that secure and streamline the development of new medicines during clinical trials. Triall’s solutions make clinical trials tamper-resistant, and enable secure and efficient integrations between the many isolated systems and parties involved in clinical trial processes. Triall’s software is created by clinical trial professionals to ensure optimal user experience, solving actual industry pain points.
Visit the website: triall.io
Twitter: twitter.com/triallofficial
Telegram community: t.me/triallcommunity
